Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2021

Jan 7, 2021

30561_dirs_2021-01-06_2a5c6502-345e-44c5-8416-cb52eb957586.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2021-01-04

Reporting Person: Hessekiel Jeffrey (EVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-17 Common Stock G 2500 Disposed 491754 Direct
2021-01-04 Common Stock M 30000 $7.27 Acquired 521754 Direct
2021-01-04 Common Stock M 20000 $1.90 Acquired 541754 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-04 Option (right to buy) $7.27 M 30000 Disposed 2021-02-09 Common Stock (30000.0) Direct
2021-01-04 Option (right to buy) $1.9 M 20000 Disposed 2022-02-04 Common Stock (20000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 999 Indirect

Footnotes

F1: Includes 108,613 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 4, 2021.

F3: The option, representing the right to purchase a total of 230,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 10, 2018.

F4: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016.